These results provide evidence that antioxidant capacity depletion by high fl-E6 levels contributes to the treatment sensitivity in HPV+ cancer; they further suggest that attenuated fl-E6 expression confers therapy resistance to certain tumors and enhances in vivo growth by mitigating oxidative stress. Here, FLT3LG is linked to cancer.